Influenza – Frontline Management and Prevention KY Pre Polling

Question Title

* 1. How confident are you CURRENTLY in your ability to evaluate clinical symptoms, risk factors for complications from influenza, diagnostic tests, and prevalence of influenza in the community to recommend antiviral treatment strategies?

Very confident

Confident

Moderately confident

Slightly confident

Not confident

Very confident

Confident

Moderately confident

Slightly confident

Not confident

Question Title

* 2. How often do you CURRENTLY educate elderly patients on the cardiovascular impact of influenza to increase vaccination uptake?

Always

Very often

Someties

Rarely

Never

Always

Very often

Someties

Rarely

Never

Question Title

* 3. Which statement about baloxavir marboxil is CORRECT?

Baloxavir is a neuraminidase inhibitor

Baloxavir was superior to placebo in reducing the time to symptom improvement in patients at high risk of influenza complications

Common adverse effects associated with baloxavir are nausea and vomiting

Oseltamivir demonstrates a faster reduction in viral shedding compared to baloxavir

Not sure

Question Title

* 4. Eleanor, a 12-year-old female with asthma, presents to your office with fever, runny nose, muscle aches, and diarrhea. Her symptoms started late the night before. The local prevalence of influenza has been on the rise for the past few weeks. She has a piano recital next weekend she does not want to miss. What would be the best next step?

Initiate antiviral therapy

Send for lab-based RT-PCR test for influenza and treat based on the results

Monitor for 2 days and reassess

Treat her symptoms with OTC medications

Not sure

Question Title

* 5. Bob, a 45-year-old male, has just started antiretroviral therapy for HIV infection. He is not ill but has a CD4 count of 112 cells/mm3. Which influenza vaccine should be avoided in this patient?

Cell culture-based quadrivalent influenza vaccine, standard dose

Inactivated quadrivalent influenza vaccine, standard dose

Live attenuated quadrivalent influenza intranasal vaccine

Recombinant influenza vaccine

Not sure

Question Title

* 6. Joan is a 36-year-old woman presenting to your office with a 3-day history of fever, malaise, and nonproductive cough. Her symptoms have gotten worse over the past 24 hours, and the cough has required her to increase use of her short-acting bronchodilator for her asthma. She lives with her husband, a 13-year-old son, and her 70-year-old mother. Her husband and son are otherwise healthy, and her mother has a medical history of diabetes and epilepsy. No one in the household has received the annual influenza vaccine. It is early January, and influenza is circulating in the community according to recent epidemiological reports.

Please select all of the following items that you CURRENTLY might employ for this patient (select all that apply)

A. Send Joan home with the following treatment plan: manage her symptoms with over-the-counter medication and supportive care, and tell her to return if she doesn’t feel better in 2 days

B.Prescribe an empiric antibiotic and antiviral therapy

C. Have Joan do a rapid influenza diagnostic test before making a decision about therapy

D. Have Joan do a rapid strep test before making a decision about therapy

E. Prescribe empiric oseltamivir treatment for Joan

F. Prescribe empiric baloxavir treatment for Joan

G. Prescribe zanamivir treatment

H. Recommend that Joan’s family members receive the influenza vaccine and that she should as well after her illness resolves

I. Prescribe antiviral prophylaxis for Joan’s husband, son, and mother